State Your Purpose: Campaign for Colorado State University raises $1.28 billion
The most successful fundraising campaign in CSU history: The $1 billion State Your Purpose: Campaign for Colorado State University has reached the finish line.
The most successful fundraising campaign in CSU history: The $1 billion State Your Purpose: Campaign for Colorado State University has reached the finish line.
Some individuals are driven by what they want to achieve; some find their passion in what they can do for others. Carole Lenz Hemmelgarn (B.A., ’86) has spent much of her professional life devoted to patient safety.
Colorado State University’s contributions to developing solutions to the COVID-19 pandemic have earned it a spot on a ranking of the top 10 universities engaged in this important research, according to the website successfulstudent.org.
Kyle Funakoshi (B.A., ’96; M.S., ’99) grew up in Fort Lupton and “found himself” during the summers of his high school years at CSU’s Upward Bound program. That experience provided him the knowledge and confidence to pursue higher education and laid the foundation for a career devoted to others.
Jennifer Clary and Fred Jacobs were annual members for a number of years, but when she received the MBA, she purchased their life membership “as a graduation present to myself.” They remain deeply involved with their alma mater.
A key part of CSU’s land grant mission is to provide access and opportunity to anyone with the motivation and ability to earn a degree. Generations of our alumni illustrate the wisdom of that mission; Jeff (B.S., ’89) and Rosie Wierenga (M.B.A., ’01) are two shining examples.
A monthly listing of alumni accomplishments, milestones, and announcements. Catch up on your classmates and submit your own announcement!
Like other biomedical companies around the globe, Salt Lake City-based Recursion jumped at the chance to help find solutions to the novel coronavirus.
A team of infectious disease researchers at Colorado State University has entered into an agreement with the Biomedical Advanced Research and Development Authority (BARDA) to further develop a novel virus inactivation process, successfully used for MERS, which has the potential to inactivate the SARS-CoV-2 virus.